John Dingell actually said...

"I am confident we can come together in a bipartisan manner to clarify and strengthen the authority of FDA over compounding pharmacies."

"This requirement will invite strict scrutiny by the courts of merger conditions imposed by the Commission."

"The draft bill then could conceivably hinder the Commission rulemakings but also severely restrict its ability to approve mergers."

"The practical effect of such challenges would be to hinder and to slow the Commission's ability to agree on new rules."